Stoke Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Stoke Therapeutics, Inc. (STOK) had Operating Leases, Future Minimum Payments, Due in Three Years of $81.00 thousand as of 2019-12-31, per its 10-Q filed 2020-11-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2020-11-12
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $81.00K.
- 2019-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $1.10M.
- 2019-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $1.10M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2019-12-31 | $81.00K 10-Q · filed 2020-11-12 |
| 2019-09-30 | $1.10M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.10M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |